Acurx Pharmaceuticals Inc (ACXP)

[Jeff4iam4]

Get them while still cheap. Buyout likely within next few months, probably by April or May at latest. Target buyout is between $20 to $38 a share. But I would not expect more than $24 due to the fact we are not in Phase 3 yet. CEO is on record that he is actively looking for a buyout forth-most or as secondary BP partner to fund the Phase 3. No way they do a offering to go Phase 3 alone and dilute the shares further. He wants to pass the burden of Phase 3 and FDA approval to a company with resources that can get this drug to market quickly. He is heavily invested not just with warrants, but with his own personal money as are a few other company officials. He also has a record of 4 out of 5 companies he has sold off after Phase 2 trials for major profit, so he is very experienced with Mergers/Acquisitions. Top line data came out showing a 94% cure rate in Phase 2b trial and 100% in the 2a trial in the past creating a 96% overall cure rate. The full data from phase 2b will be out by December and if it shows clear separation in sustained cure over Vancomycin (current standard of care drug) then this company will be easily sold to competitive bidding by several BPs. The chances of showing that separation of sustainable cure rate is high as it was shown to be 100% in the previous 2a trial.